Back
MediciNova, Inc. 10K Form
Sell
47
MNOV
MediciNova, Inc.
Last Price:
$1.56
Seasonality Move:
1.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | MNOV/MediciNova, Inc. Quarterly |
| 2023-11-09 | 10Q | MNOV/MediciNova, Inc. Quarterly |
| 2023-08-09 | 10Q | MNOV/MediciNova, Inc. Quarterly |
| 2023-05-11 | 10Q | MNOV/MediciNova, Inc. Quarterly |
| 2022-11-10 | 10Q | MNOV/MediciNova, Inc. Quarterly |
| 2022-08-11 | 10Q | MNOV/MediciNova, Inc. Quarterly |
Receive MNOV News And Ratings
See the #1 stock for the next 7 days that we like better than MNOV
MNOV Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.90 |
| Price / Book: | 1.74 |
Profitability
| EPS (TTM): | -0.24490 |
|---|---|
| Net Income (TTM): | $-12M |
| Gross Margin: | $-21.1K |
| Return on Equity: | -24.18% |
| Return on Assets: | -22.76% |
MediciNova, Inc. Earnings Forecast
Key MediciNova, Inc. Financial Ratios
-
Per Share Earnings over the last 24 years have been positive in 13 years.
MediciNova, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MNOV |
| CUSIP: | 58468P |
| Website: | medicinova.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 9.86 |
| Quick Ratio: | 9.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MNOV Technical Analysis vs Fundamental Analysis
Sell
47
MediciNova, Inc. (MNOV)
is a Sell
Is MediciNova, Inc. a Buy or a Sell?
-
MediciNova, Inc. stock is rated a SellThe current MediciNova, Inc. [MNOV] share price is $1.56. The Score for MNOV is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.